Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.29%

Neostem, Inc. (NBS)

-NasdaqCM
2.26 Up 0.14(6.60%) Jun 2, 4:00PM EDT
|After Hours : 2.25 Down 0.01 (0.44%) Jun 2, 7:47PM EDT
Add to Portfolio
Prev Close:2.12
Open:2.16
Bid:2.22 x 500
Ask:2.58 x 2000
1y Target Est:13.50
Beta:1.37
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:2.13 - 2.29
52wk Range:2.03 - 7.23
Volume:1,188,890
Avg Vol (3m):722,788
Market Cap:90.74M
P/E (ttm):N/A
EPS (ttm):-1.72
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NBSUp 6.60%90.74M
BAXUp 0.03%36.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.36
Quarterly EPS Est (Jun-15) :-0.33
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback